NEW YORK, NY--(Marketwire - Feb 20, 2013) - Shares of major health insurers fell Tuesday after analysts stated that proposed reductions in government payments for Medicare Advantage insurance plans would be "unfavorable" for companies. Medicare Advantage is a health insurance program offered by a private provider. Research Driven Investing examines investing opportunities in the Health Care Plans Industry and provides equity research on Aetna Inc. (
Access to the full company reports can be found at:
Last Friday, the Centers for Medicare and Medicaid Services stated that in 2014 proposed Medicare Advantage rates will decline more than 2 percent. Goldman Sachs analyst Matthew Borsch in a not to investors stated the proposal is "sharply unfavorable" and "significantly worse than expected".
"These changes will disrupt coverage for Medicare Advantage beneficiaries at a time when evidence clearly demonstrates that Medicare Advantage provides higher-quality care than the fee-for-service part of Medicare," Karen Ignagni, president of America's Health Insurance Plans, said in a statement.
Research Driven Investing releases regular market updates on the Biotech Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and industry newsletters.
Aetna is one of the nation's leading diversified health care benefits companies, serving approximately 37.3 million people with information and resources to help them make better informed decisions about their health care. The company reported a net income of $190.1 million, or $.56 per share, in the fourth quarter. Aetna's Board of Directors has recently declared a quarterly dividend of $0.20 per share.
WellCare Health Plans, Inc. provides managed care services targeted to government-sponsored health care programs, focusing on Medicaid and Medicare. The company serves approximately 2.7 million members nationwide as of Dec. 31, 2012. WellCare reported premium revenues increased 24 percent year-over-year to $2 billion in the fourth quarter.
Research Driven Investing has not been compensated by any of the above-mentioned publicly traded companies. Research Driven Investing is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at: